S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
NASDAQ:DYAI

Dyadic International (DYAI) Stock Price, News & Analysis

$1.67
+0.04 (+2.45%)
(As of 03/28/2024 ET)
Today's Range
$1.64
$1.73
50-Day Range
$1.29
$1.67
52-Week Range
$1.19
$2.40
Volume
29,930 shs
Average Volume
21,873 shs
Market Capitalization
$48.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

Dyadic International MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
259.3% Upside
$6.00 Price Target
Short Interest
Bearish
0.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.13mentions of Dyadic International in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.23) to ($0.25) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.50 out of 5 stars

Medical Sector

752nd out of 938 stocks

Biological Products, Except Diagnostic Industry

120th out of 149 stocks

DYAI stock logo

About Dyadic International Stock (NASDAQ:DYAI)

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. It utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus-like particles, protein antigens, ferritin nanoparticles, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to demonstrate the safety in humans of a protein produced from C1-cell protein production platform. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; and strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U., as well as co-development and marketing agreement with Fermbox Bio Inc to design,Develop, and commercialize animal free alternative proteins and biomaterials The company was founded in 1979 and is headquartered in Jupiter, Florida.

DYAI Stock Price History

DYAI Stock News Headlines

Recap: Dyadic International Q4 Earnings
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Dyadic to Attend Industry Events in April
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Dyadic to Attend Industry Events in March
DYAI Aug 2024 2.500 call
DYAI Apr 2024 2.500 call
DYAI: Catching Up With Dyadic
See More Headlines
Receive DYAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dyadic International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:DYAI
Employees
7
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.00
High Stock Price Target
$6.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+259.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-9,730,000.00
Net Margins
-232.38%
Pretax Margin
-232.38%

Debt

Sales & Book Value

Annual Sales
$2.93 million
Book Value
$0.39 per share

Miscellaneous

Free Float
20,946,000
Market Cap
$48.11 million
Optionable
Optionable
Beta
0.58
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

DYAI Stock Analysis - Frequently Asked Questions

Should I buy or sell Dyadic International stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dyadic International in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" DYAI shares.
View DYAI analyst ratings
or view top-rated stocks.

What is Dyadic International's stock price target for 2024?

1 Wall Street research analysts have issued 12 month price targets for Dyadic International's stock. Their DYAI share price targets range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 259.3% from the stock's current price.
View analysts price targets for DYAI
or view top-rated stocks among Wall Street analysts.

How have DYAI shares performed in 2024?

Dyadic International's stock was trading at $1.61 at the beginning of the year. Since then, DYAI shares have increased by 3.7% and is now trading at $1.67.
View the best growth stocks for 2024 here
.

Are investors shorting Dyadic International?

Dyadic International saw a increase in short interest in March. As of March 15th, there was short interest totaling 185,900 shares, an increase of 8.1% from the February 29th total of 171,900 shares. Based on an average trading volume of 23,600 shares, the short-interest ratio is currently 7.9 days. Currently, 0.9% of the company's shares are short sold.
View Dyadic International's Short Interest
.

How were Dyadic International's earnings last quarter?

Dyadic International, Inc. (NASDAQ:DYAI) posted its quarterly earnings results on Wednesday, November, 10th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.09) by $0.03. The biotechnology company had revenue of $0.69 million for the quarter, compared to the consensus estimate of $0.61 million. Dyadic International had a negative net margin of 232.38% and a negative trailing twelve-month return on equity of 71.31%. During the same quarter in the prior year, the business posted ($0.09) EPS.

What other stocks do shareholders of Dyadic International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dyadic International investors own include Silvercorp Metals (SVM), Endeavour Silver (EXK), Hecla Mining (HL), Pfizer (PFE), Advanced Micro Devices (AMD), Endeavour Silver (EDR), Mandalay Resources (MND), Alibaba Group (BABA) and Chimerix (CMRX).

Who are Dyadic International's major shareholders?

Dyadic International's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Chapin Davis Inc. (2.87%), Vanguard Group Inc. (2.79%), Vanguard Group Inc. (2.79%), Citadel Advisors LLC (0.00%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Francisco Trust Under Agreemen, Mark A Emalfarb, Ping Wang Rawson and Ronen Tchelet.
View institutional ownership trends
.

How do I buy shares of Dyadic International?

Shares of DYAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DYAI) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners